Keyword: Bristol-Myers Squibb (BMS)
News
18.02.2019
- Within a week, US biotech Celgene, which is in the process of being acquired by Bristol-Myers-Squibb (BMS), dodged a challenge to its patent for the blockbuster multiple myeloma...
News
05.02.2019
- The proposed $74 billion takeover of US biotech Celgene by compatriot BristolMyers Squibb (BMS), announced last month, may be looking somewhat shaky. Analysts and investors up to...
News
07.01.2019
- In the first major pharma deal of the year, Bristol-Myers Squibb (BMS) is to acquire biotech giant Celgene for $74 billion. The cash-and-stock transaction values the US biotech at...
Markets & Companies
29.11.2018
- As part of its journey toward being a full-fledged advanced economy, the role and presence of China within the pharmaceutical industry has rapidly evolved throughout the recent...
News
05.07.2018
- Johnson & Johnson (J&J) has won its third appeal of a verdict implicating its talc-based baby powder in a user’s cancer on a technicality. The Missouri Court of Appeals overturned...
News
14.05.2018
- Drugmaker Bristol-Myers Squibb (BMS) and Flatiron Health, a privately held healthcare technology and services company – both are headquartered in New York City – have extended...
News
26.02.2018
- US drugmaker Bristol-Myers Squibb has struck a deal worth $3.6 billion with biotech Nektar Therapeutics to jointly develop and commercialize the latter’s lead anticancer molecule –...
News
13.10.2017
- Pfizer is reviewing the future of its Consumer Healthcare division. The US drug major said it is considering a range of options, including a full or partial separation through a...
